市場調查報告書
商品編碼
1541004
2024-2032 年骨科軟組織修復市場報告(按手術、損傷部位、最終用戶和地區)Orthopedic Soft Tissue Repair Market Report by Procedure, Injury Location, End User, and Region 2024-2032 |
2023年,全球骨科軟IMARC Group修復市場規模達36億美元。老年人口的增加、醫療領域技術的不斷進步、身體活動參與度的增加等是推動市場成長的主要因素。
主要市場促進因素:個人擴大參與職業運動,顯著增加了運動相關傷害的風險,這反過來又促進了骨科軟組織修復市場的需求。此外,新療法的引入,例如富含血小板的血漿,可以有效治療由於骨科韌帶撕裂引起的複雜神經肌肉疼痛,正在促進該行業的成長。
主要市場趨勢:生物列印、生物網格和生物製造等先進技術的日益普及預計將擴大骨科軟組織修復市場需求。此外,廣泛的研發(R&D)活動、新設備和療法的創新以及人均醫療保健支出的增加也促進了市場的成長。
競爭格局:骨科軟組織修復市場的一些領先公司包括 Arthrex Inc.、Becton Dickinson and Company、Boston Scientific Corporation、CONMED Corporation、Integra LifeSciences、Johnson & Johnson、LifeNet Health、MTF Biologics、Smith & Nephew plc、Stryker Corporation 、Tissue Regenix Group plc 和Zimmer Biomet 等。
地理趨勢:北美和歐洲市場在骨科軟組織修復市場中佔有顯著佔有率。許多因素,如人口老化、運動相關傷害的高發生率、先進的醫療基礎設施和健全的報銷體系,都促進了這些地區的市場成長。此外,在亞太地區,醫療基礎設施的改善、可支配收入的增加以及對先進治療方案的認知不斷增強,推動了市場的擴張。
挑戰與機會:軟組織手術的成本控制、監管障礙、技術複雜性以及主要參與者之間的激烈競爭是市場面臨的一些主要挑戰。然而,持續的研究和開發工作導致了用於軟組織修復的創新技術和生物材料的開發,改善了手術結果並縮短了患者的康復時間,從而擴大了行業需求。
骨科損傷發生率上升
骨科損傷發生率的增加極大地推動了骨科軟組織修復市場的發展。人們擴大參與體育活動和體育運動,導致骨科損傷發生率上升。根據美國國家運動訓練師協會的數據,到 2022 年,美國約有 3,000 萬名兒童參與有組織的運動。這進一步增加了運動傷害的數量。例如,根據美國疾病管制與預防中心 (CDC) 發表的一篇文章,美國每年發生超過 350 萬起與運動相關的傷害。除此之外,2022 年在加拿大進行的一項研究顯示,加拿大高中接觸運動參與者受傷的比例很高。調查還發現,受傷率從橄欖球每 100 名參與者每年 12.7 人到冰球每 100 名參與者每年 33.1 人不等。頭部外傷盛行率為33.3%;手腕或手部受傷率為 16.0%;肩部受傷率為12.8%;膝蓋受傷率為12.0%。這涵蓋了輕傷和災難性傷害。隨著人們從事更多的體力活動和運動,軟組織受傷的可能性就會增加。這些損傷的範圍從韌帶撕裂到肌腱斷裂,需要手術介入來修復。除此之外,人口老化,加上骨關節炎等慢性病的盛行率較高,也推動了對骨科干預措施(包括軟組織修復)的需求。例如,根據克利夫蘭診所發表的一篇文章,超過 80% 的 55 歲以上成年人患有骨關節炎。此外,隨著人們對骨科健康重要性的認知不斷增強以及醫學知識的進步,越來越多的人正在尋求骨科損傷的治療,從而推動了對軟組織修復手術的需求。這些因素正在支撐骨科軟組織市場收入。
老年人口和肥胖率不斷上升
人口老化和慢性病發病率的上升極大地推動了軟組織修復市場的發展。例如,根據世界衛生組織的數據,到 2030 年,世界上每 6 個人中就有 1 人年齡在 60 歲或以上。屆時,60歲以上人口比例將從2020年的10億上升至14億。到 2050 年,全球 60 歲及以上人口將翻倍(21 億)。預計 2020 年至 2050 年間,80 歲及以上的人口數量將增加兩倍,達到 4.26 億。肥胖率的顯著上升導致糖尿病、心血管和腎臟相關疾病等慢性疾病的發生率不斷增加。例如,根據世界衛生組織2023年發布的報告,2014年,18歲以上成年人中有8.5%患有糖尿病。 2019年,糖尿病是造成150萬人死亡的直接原因,其中48%發生在70歲前。 2000年至2019年間,年齡標準化糖尿病死亡率增加了3%。在低收入和中等收入國家,糖尿病相關死亡率增加了 13%。此外,根據美國骨科醫師學會發表的一篇文章,肥胖通常與軟組織損傷和骨關節炎(一種關節的退化性磨損狀況)有關。肥胖對髖關節和膝關節的骨關節炎有顯著影響。每磅人體重量會對每個膝關節施加四到六磅的壓力。肥胖者需要膝關節置換的可能性是非超重者的 20 倍。這些因素進一步提高了骨科軟組織修復市場佔有率。
技術進步
技術進步在推動骨科軟組織修復市場的成長中發揮著至關重要的作用。這些進步有助於開發更有效、更侵入性的治療方案,提高患者治療效果並縮短復原時間。此外,技術創新促進了微創手術技術的發展,例如關節鏡檢查和腹腔鏡檢查,與傳統的開放性手術相比,可以減少對周圍組織的創傷,最大限度地減少疤痕並加快恢復時間。例如,2023年7月,全球醫療科技公司Smith + Nephew在印度推出了REGENETEN生物感應植入物。 REGENETEN 植入物改變了外科醫生進行肩袖手術的方式,自推出以來已在全球範圍內實施了超過 100,000 例手術。基於膠原蛋白的 REGENETEN 生物感應植入物刺激了身體的自然癒合反應,允許新的肌腱樣組織的發育,自然地增強當前的肌腱並改變疾病的進展。大約郵票大小的植入物透過關節鏡透過肩袖肌腱損傷區域的小切口進行遞送。除此之外,主要參與者的各種發展也增加了對組織修復的需求。例如,2021 年 8 月,Orthopedic Implant Company 推出了經 FDA 批准的 DRPX 腕部骨折接骨板,該接骨板採用 II 型陽極氧化鈦合金以及薄型接骨板和螺絲設計,可減少軟組織撞擊。這些因素對骨科軟組織修復市場預測有正面影響。
The global orthopedic soft tissue repair market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The rising geriatric population, continuous technological advancements in the medical sector, growing participation in sports activities, etc., are some of the major factors propelling the market growth.
Major Market Drivers: The growing participation of individuals in professional sports has significantly increased the risks of sports-related injuries, which, in turn, is facilitating the orthopedic soft tissue repair market demand. Moreover, the introduction of new therapies, such as platelet-rich plasma, that are effective in managing complex neuromuscular pain caused due to orthopedic ligament tears is proliferating the industry's growth.
Key Market Trends: The increasing penetration of advanced technologies, including bioprinting, biological meshes, and bio-fabrication is anticipated to proliferate the orthopedic soft tissue repair market demand. In addition, extensive research and development (R&D) activities, innovations in new devices and therapies, and increasing healthcare per capita expenditure, are also contributing to the market growth.
Competitive Landscape: Some of the leading orthopedic soft tissue repair market companies are Arthrex Inc., Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Integra LifeSciences, Johnson & Johnson, LifeNet Health, MTF Biologics, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Group plc, and Zimmer Biomet, among others.
Geographical Trends: The North America and Europe markets hold prominent shares of the orthopedic soft tissue repair market. Numerous factors, such as a large aging population, high prevalence of sports-related injuries, advanced healthcare infrastructure, and robust reimbursement systems, contribute to the market growth in these regions. Moreover, in the Asia Pacific region, improving healthcare infrastructures, rising disposable incomes, and growing awareness of advanced treatment options drive the market expansion.
Challenges and Opportunities: Cost containment of soft tissue procedures, regulatory hurdles, technological complexity, and high competition among key players are some of the major challenges that the market is facing. However, ongoing research and development efforts lead to the development of innovative technologies and biomaterials for soft tissue repair, improving procedural outcomes and patient recovery times, thereby escalating the industry demand.
Rising Incidences of Orthopedic Injuries
The increasing occurrence of orthopedic injuries is significantly propelling the orthopedic soft tissue repair market forward. Rising participation in physical activities and sports is leading to a rise in the incidence of orthopedic injuries. According to the National Athletic Trainers' Association, around 30 million children participated in organized sports in the United States in 2022. This figure has risen over time, as youth sports leagues have grown in popularity. This is further escalating the number of sports injuries. For instance, according to an article published by the Centers for Disease Control and Prevention (CDC), over 3.5 million sports-related injuries occur each year in the United States. In addition to this, a study conducted in Canada in 2022 revealed a significant percentage of injuries among contact sports participants in Canadian high schools. The survey also found that injury rates varied from 12.7 per 100 participants per year in rugby to 33.1 per 100 participants per year in ice hockey. The prevalence rate of head injuries was 33.3%; wrist or hand injuries were 16.0%; shoulder injuries were 12.8%; and knee injuries were 12.0%. This covers both minor and catastrophic injuries. As people engage in more physical activities and sports, the likelihood of sustaining soft tissue injuries rises. These injuries can range from ligament tears to tendon ruptures, requiring surgical intervention for repair. Apart from this, the aging population, coupled with a higher prevalence of chronic conditions such as osteoarthritis, also drives the demand for orthopedic interventions, including soft tissue repair. For instance, according to an article published by the Cleveland Clinic, more than 80% of adults older than 55 had osteoarthritis. Furthermore, with growing awareness about the importance of orthopedic health and advancements in medical knowledge, more people are seeking treatment for orthopedic injuries, driving the demand for soft tissue repair procedures. These factors are bolstering the orthopedic soft tissue market revenue.
Escalating Geriatric Population and Obesity Rates
The rise in the aging population and chronic disease occurrences is significantly driving the soft tissue repair market. For instance, according to the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up would rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of people aged 60 and up would double (2.1 billion). The number of people aged 80 and older was anticipated to treble between 2020 and 2050, reaching 426 million. The significant rise in obesity rates is leading to the increasing incidence of chronic diseases such as diabetes, and cardiovascular and kidney-related illnesses. For instance, according to a report published by the World Health Organization in 2023, in 2014, 8.5% of adults aged 18 and up had diabetes. In 2019, diabetes was the direct cause of 1.5 million fatalities, with 48% occurring before the age of 70. Diabetes caused an additional 460,000 renal disease deaths, and high blood glucose was responsible for approximately 20% of cardiovascular fatalities. Between 2000 and 2019, age-standardized diabetes mortality rates increased by 3%. Diabetes-related mortality has increased by 13% in low- and middle-income nations. Moreover, according to an article published by the American Academy of Orthopedic Surgeons, obesity is usually associated with soft tissue injury and osteoarthritis, a degenerative wear and tear condition of the joints. Obesity has a significant impact on osteoarthritis of the hip and knee joints. Every pound of human weight applies four to six pounds of pressure on each knee joint. Obese people are 20 times more likely to require a knee replacement than those who are not overweight. These factors are further contributing to the orthopedic soft tissue repair market share.
Technological Advancements
Technological advancements play a crucial role in driving the growth of the orthopedic soft tissue repair market. These advancements contribute to the development of more effective and less invasive treatment options, enhancing patient outcomes and reducing recovery times. Moreover, technological innovations have led to the development of minimally invasive surgical techniques, such as arthroscopy and laparoscopy, which reduce trauma to surrounding tissues, minimize scarring, and accelerate recovery times compared to traditional open surgeries. For instance, in July 2023, Smith+Nephew, the worldwide medical technology business, launched REGENETEN bioinductive implant in India. The REGENETEN implant has transformed the way surgeons approach rotator cuff surgeries, with over 100,000 procedures conducted globally since its inception. The collagen-based REGENETEN bioinductive implant stimulated the body's natural healing response, allowing the development of new tendon-like tissue to naturally enhance the current tendon and alter disease progression. The implant, roughly the size of a postage stamp is delivered arthroscopically through a small incision over the region of the rotator cuff tendon injury. Apart from this, various developments by the key players are also enhancing the demand for tissue repair. For example, in August 2021, Orthopaedic Implant Company introduced its FDA-cleared DRPX wrist fracture plate, which features type II anodized titanium and a low-profile plate and screw design to reduce soft tissue impingement. These factors are positively influencing the orthopedic soft tissue repair market forecast.
IMARC Group provides an analysis of the key trends in each segment of the global orthopedic soft tissue repair market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on procedure, injury location, and end user.
Cruciate Ligaments Repair
Rotator Cuff Repair
Lateral Epicondylitis
Achilles Tendinosis Repair
Pelvic Organ Prolapse
Gluteal Tendon Repair
Hip Arthroscopy
Biceps Tenodesis
Others
The report has provided a detailed breakup and analysis of the market based on the procedure. This includes cruciate ligaments repair, rotator cuff repair, lateral epicondylitis, achilles tendinosis repair, pelvic organ prolapse, gluteal tendon repair, hip arthroscopy, biceps tenodesis, and others.
According to the orthopedic soft tissue repair market outlook, cruciate ligaments repair is commonly performed to reconstruct a torn anterior cruciate ligament (ACL) in the knee, which often occurs during sports injuries. Demand for this procedure tends to be consistent due to the prevalence of sports-related injuries. While rotator cuff repair is a group of muscles and tendons that stabilize the shoulder joint. Tears in the rotator cuff are common, especially among older adults and athletes engaged in overhead activities. The demand for rotator cuff repair remains steady due to the aging population and continued participation in sports. Moreover, lateral epicondylitis, commonly known as tennis elbow, is inflammation of the tendons that join the forearm muscles on the outside of the elbow. Treatment options include conservative measures like rest, physical therapy, and corticosteroid injections, but in some cases, surgical intervention may be necessary.
Knee
Shoulder
Hip
Small Joints
A detailed breakup and analysis of the market based on the injury location have also been provided in the report. This includes knee, shoulder, hip, and small joints.
According to the orthopedic soft tissue repair market outlook, the demand for soft tissue repair procedures in the knee, shoulder, hip, and small joints can vary based on several factors, including the prevalence of injuries, demographic trends, advancements in surgical techniques, and changes in patient preferences. There has been a noted increase in the incidence of ACL knee tears, especially among young athletes participating in high-impact sports like soccer, basketball, and football. Factors contributing to this rise may include increased sports participation, year-round training, and higher intensity levels. Moreover, there has been a rise in rotator cuff injuries in the shoulder, particularly among individuals over 40, possibly due to aging demographics, increased sports participation among older adults, and occupational demands.
Hospitals
Ambulatory Centers
Orthopedic Clinics
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals, ambulatory centers, and orthopedic clinics.
Hospitals often handle acute soft tissue injuries requiring immediate attention, such as traumatic ligament tears, tendon ruptures, or severe joint dislocations. Soft tissue repair procedures performed in hospitals may include complex surgeries or revisions. Hospitals can accommodate patients requiring overnight stays or post-operative monitoring, which may be necessary for certain soft tissue repair procedures with extended recovery periods or higher risk profiles. Moreover, ASCs are increasingly popular for performing elective soft tissue repair procedures that do not require overnight hospitalization, such as arthroscopic surgeries for meniscal tears or rotator cuff repairs. Apart from this, orthopedic clinics focus exclusively on musculoskeletal conditions and surgeries, including soft tissue repair procedures. Patients seeking specialized orthopedic care may prefer these clinics for comprehensive evaluations, treatment planning, and post-operative rehabilitation.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
According to the orthopedic soft tissue market statistics, the North America region, including the United States and Canada, has well-established medical systems with high levels of healthcare expenditure. Factors such as a large aging population, increasing sports participation, and advancements in medical technology drive the demand for orthopedic soft tissue repair procedures. Moreover, in Europe, countries like Germany, France, and the United Kingdom, have sophisticated healthcare infrastructure and high demand for orthopedic procedures. Additionally, the orthopedic soft tissue repair market in the Asia Pacific region is rapidly expanding due to urbanization, the aging population, and increasing healthcare expenditures. The government's healthcare reforms and investments in medical infrastructure further boost the market growth.
Arthrex Inc.
Becton Dickinson and Company
Boston Scientific Corporation
CONMED Corporation
Integra LifeSciences
Johnson & Johnson
LifeNet Health
MTF Biologics
Smith & Nephew plc
Stryker Corporation
Tissue Regenix Group plc
Zimmer Biomet
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
June 2024: Stryker Corporation, a medical technology firm, acquired Artelon, a soft tissue fixation products provider. The agreement was aimed at enhancing Stryker's offerings in the sports medicine segment.
May 2024: The Center of Generative Medicine at the Hospital for Special Surgery, with a sub-site at Emory University, conducted a trial to investigate whether using concentrated bone marrow aspirate could help patients to heal more effectively.
May 2024: The Palm Beach Orthopedic Institute stated that a board-certified specialist in orthopedic care made a significant contribution to orthopedic surgery by performing his first procedure with the X-Twist Fixation System with bio composite anchors. This process involves advanced procedures ranging from single or double-row repairs to knotless and completely knotted structures for soft tissue and bone repairs.